We use cookies to analyze site usage and improve your experience. You can accept all, reject non-essential, or customize. See our Privacy Policy.
Journal
Evidence-based articles on menopause, metabolic health, and hormones — physician-reviewed.
Evidence & Policy
One 2002 press conference reshaped a generation of care. Here is what the Women’s Health Initiative actually found, what was misread, and where the guidelines stand now.
July 26, 2026
Read →Metabolic Menopause
Estrogen loss reshapes insulin sensitivity, fat distribution, and mitochondrial function. Here is what "metabolic menopause" really means — and the protocol that reverses it.
July 25, 2026
Read →Metabolic Menopause
Fasting insulin rises years before fasting glucose. Here is how to catch perimenopausal insulin resistance early and reverse it.
July 25, 2026
Read →Metabolic Menopause
Menopausal weight gain is not just weight — it is a shift toward visceral fat, the most metabolically dangerous fat depot. Here is how to reverse it.
July 25, 2026
Read →Metabolic Menopause
Metabolic syndrome affects roughly 40% of postmenopausal women. Here are the five markers, why they cluster after menopause, and the protocol that reverses them.
July 25, 2026
Read →Menopause Peptides
Peptide therapy is having a moment in menopause care. Here is a clinician-reviewed breakdown of which peptides have real evidence in midlife women — and which do not.
July 25, 2026
Read →Menopause Peptides
BPC-157 is the most-studied repair peptide in circulation. Here is how midlife women are using it for joint pain, tendon injury, and gut inflammation.
July 25, 2026
Read →Menopause Peptides
The most common growth-hormone-secretagogue combination in midlife women. Here is how it works, what it does, and where the evidence stands.
July 25, 2026
Read →Menopause Peptides
AOD-9604 is a small fragment of growth hormone that promotes fat oxidation without affecting blood sugar. Here is how it fits into menopause fat-loss protocols.
July 25, 2026
Read →GLP-1 & Metabolic
Six state Medicaid programs ended GLP-1 weight-loss coverage in 2026. The drugs did not change. The budgets did. Here is what happened, and what patients on the wrong side of the line can still do.
July 25, 2026
Read →Evidence & Policy
Black cohosh, red clover, evening primrose, soy isoflavones, maca, DIM. A plain reading of the trial evidence — and the four supplements that do have a defensible role.
July 25, 2026
Read →Evidence & Policy
The menopause market is booming while mainstream midlife care stands still. Here is what the money is actually buying, and the four things an honest menopause service owes you.
July 24, 2026
Read →Evidence-based menopause guidance from the Kindr Health clinical team and our medical advisory board. Weekly. No spam.
By subscribing you agree to our Privacy Policy. Unsubscribe anytime.